Abstract:BACKGROUND:Hepatocellular carcinoma (HCC) is one of the most common cancer-related causes of death worldwide. The epidermal growth factor receptor (EGFR) is highly expressed in many human tumors and provides a new target for anticancer drug development. The aim of the present study was to explore the effect of EGFR antisense oligodeoxynucleotide on human HCC.METHODS:SMMC-7721 cells in culture were treated with 10 mumol/L antisense-odn for 24, 48, 72 hours respectively and MTT assay was adopted to determine the proliferation of tumor cells in vitro. About 2 x 10(6) SMMC-7721 cells with or without pretreatment(30 micromol/L oligodeoxynucleotide) were inoculated into subcutaneous flap of 21 nude mice, of which 7 were treated with EGFR antisense-odn, 7 with scrambled oligodeoxynucleotide (scrambled-odn), and 7 not treated in vivo.RESULTS:In vitro, after 24, 48, 72 hours the inhibitory rate of proliferation of SMMC-7721 cells treated with EGFR antisense-odn was 8%, 32%, and 34% respectively. In vivo after 8 weeks, no palpable tumor was found in 1/7 mice receiving cells pretreated with antisense-odn, whereas 7/7 untreated mice and 6/7 mice treated with scrambled-odn developed palpable tumors. Tumor growth in antisense-odn treated mice was significantly inhibited in comparison with that of those untreated (P < 0.01) or treated with scrambled-odn (P < 0.05).CONCLUSIONS:Antisense oligodeoxynucleotide acts as a specific growth inhibitor on SMMC-7721 in a sequence specific and time-dependent manner. EGFR antisense-odn can significantly inhibit the proliferation of human hepatoma cell in vitro as well as in vivo, indicating that EGFR may play an important role in the development of hepatoma and will be a new target for its treatment.

The screening of the sensitive antisense target in the ODCmRNA

Bc047440 Antisense Eukaryotic Expression Vectors Inhibited Hepg(2) Cell Proliferation and Suppressed Xenograft Tumorigenicity

In Vitro Inhibition of Antisense RNA of Ornithine Decarboxylase Gene on Lung Cancer Cell A-549

Inhibitory Effect of EGFR Antisense Oligodeoxynucleotide on Human Hepatoma Cell Line.

Inhibition of Prostate Cancer Cells with Antisense RNA of Ornithine Decarboxylase Gene

The Research for Associativity of ODC Genetic Expression with Lung Cancer in Vitro

Cloning and Expression of Ornithine Decarboxylase Gene from Human Colorectal Carcinoma

Inhibitory Effect Of Antisense Rna Of Ornithine Decarboxylase Gene On Human Esophageal Squamous Carcinoma Cell Line Eca109

Construction of an Antisense RNA Recombinant Adenovirus Vector of the Third Extron in ODC Gene

[Inhibitory Effects of ODC and AdoMetDC Bi-Antisense Virus on the Growth and Invasion of Lung Cancer Cell A-549].

Experimental Study of Inhibition of Multidrug Resistance of Rat Glioma Cells (C6) by Antisense Oligodeoxynucleotides

Selection of antisense oligonucleotides for reversal of multidrug resistance in breast carcinoma cells.

EFFECT OF INHIBITING MDR1 ON RADIOSENSITIVITY IN HEPATOCELLUAR CARCINOMA XENOGRAFTS

Lentiviral vector-mediated downregulation of ornithine decarboxylase inhibits tumor cell growth in vitro and in vivo.

Exploration of Differential Expressed Genes Involved in the Development and Progression of Hepatocellular Carcinoma Using Oligomicroarray

Inhibition of lung cancer cell A-549 by rAd-ODC/Ex3as

Construction and Identification of a Prostatic Androgen-Independent Promoter Mediated ODC and AdoMetDC Antisense RNA-expressing Adenovirus

Screening of Binding Proteins Interact with Phosphotyrosine-Interacting Domain of DOC-2 by Yeast Two Hybrid System

Suppression Subtractive Hybridization for Screening of Upregulated Gene Expressions in Interferon-Alpha Transfected HepG2 Cell Line

Screening and Identification of Antisense Accessible Sites of Survivin {\sl in Vitro}

Targeted antitumor effect induced by hTERT promoter mediated ODC antisense adenovirus